Monitor for future commercial adoption metrics or expanded co-marketing efforts, but expect minimal near-term financial impact. This is a workflow enhancement, not a revenue driver.
Price Chart
Executive Summary
PacBio announced that Lucid Genomics has joined its PacBio Compatible partner program, integrating its cloud-native bioinformatics platform for tertiary analysis of long-read sequencing data. This collaboration enables seamless, validated workflows from sequencing to clinical or research insights, enhancing the utility of PacBio's HiFi technology.
Key Facts
- Lucid Genomics joined PacBio's Compatible partner program to support tertiary analysis of PacBio-generated long-read sequencing data.
- Integration focuses on enabling streamlined variant calling, structural variant detection, methylation analysis, and clinical interpretation.
- Lucid Genomics' platform is cloud-native and purpose-built for long-read sequencing, specifically optimized for PacBio's HiFi data.
Financial Impact
No immediate financial impact disclosed; partnership is strategic and ecosystem-focused.
Risk Factors
- Limited near-term revenue contribution from the partnership.
- Dependence on third-party adoption of integrated solution by labs and research institutions.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3278067 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | Press Release | $1.84 $2.27 | ▲ +23.10% | ▲ +23.24% | $2.25 (+22.28%) |
Oct 6, 2026 20d ago | 144 | $2.72 $1.99 | ▲ +26.84% | ▲ +25.86% | $2.25 (+17.28%) |
Oct 6, 2026 20d ago | Press Release | $2.70 $2.05 | ▼ −24.07% | ▼ −23.94% | $2.25 (−16.67%) |
Jun 4, 2026 20w ago | 8-K | $1.45 $1.31 | ▼ −9.66% | ▼ −10.22% | $2.25 (+55.17%) |
May 22, 2026 22w ago | DEFA14A | $1.26 $1.58 | ▲ +25.40% | ▲ +24.31% | $2.25 (+78.57%) |
Apr 21, 2026 26w ago | Press Release | $1.73 $1.58 | ▼ −8.67% | ▼ −9.75% | $2.25 (+30.06%) |
Apr 16, 2026 27w ago | Press Release | $1.69 $1.56 | ▼ −7.69% | ▼ −8.25% | $2.25 (+33.14%) |
Mar 5, 2026 33w ago | 8-K | $1.52 $1.27 | ▼ −16.45% | ▼ −14.21% | $2.25 (+48.03%) |
Mar 3, 2026 34w ago | Insider Cluster | $1.52 $1.37 | ▼ −9.87% | ▼ −9.39% | $2.25 (+48.03%) |
Feb 28, 2026 34w ago | Institutional Cluster | $1.62 $1.39 | ▼ −14.20% | ▼ −12.99% | $2.25 (+38.89%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers